Primary Contact
Ryan Pardo
Ryan.Pardo@usrenalcare.com
KCE Participants
Dialysis Facilities
| USRC Atascosa County Dialysis LLC |
USRC Edinburg LP |
| USRC SA Bandera Road LLC |
USRC McAllen LP |
| US Renal Care Boerne LLC |
USRC Mid Valley Weslaco LP |
| USRC San Saba LLC |
USRC Mission LP |
| USRC Gateway Dialysis LLC |
USRC Valley McAllen LP |
| USRC Hill Country, LLC |
USRC SA Tri County LLC |
| USRC Eagle Pass LLC |
USRC Live Oak LLC |
| USRC Medical Center LLC |
USRC SA Houston Street, LLC |
| USRC Medina County Dialysis LLC |
USRC Harlingen LP |
| USRC SA Pleasanton Road LLC |
USRC North Harlingen, LLC |
| USRC San Antonio Home Therapies LLC |
USRC San Benito Dialysis Ltd |
| USRC South San Antonio LLC |
USRC Rio Grande LP |
| DSI Southeast San Antonio, LLC |
USRC Laredo South LP |
| USRC Westover Hills LLC |
USRC Laredo LP |
| USRC Conway LLC |
USRC Las Canteras, LLC |
| USRC Delta LP |
USRC Dialysis at Home West LLC |
| USRC Datapoint, LLC |
RSA – Schertz, LLP |
Practices
Andrew Levine MD PA
Dr. Maria Monette Regalado M.D.
M Reza Mizani MD PA
| Marisa Narvaez |
Luis Velez |
| Carl Dukes |
Mohammad Mizani |
| Carolina Arias-Cuello |
Naushad Zafar |
| Christine Mitchell |
Pavan Devulapally |
| Esteban Cedillo-Couvert |
Reza Ali |
| Francois Jo Hoy |
Saqib Syed |
| Indraneel Mogarala |
Shirin Sharma |
| Lauren Tarbox |
Steven Rosenblatt |
| Lucille Abas |
Varshasb Broumand |
| Ashton Lee |
Maribel Kamp |
| Phoebe Magdales |
Carmelo Otero |
| Sarahy Oramas |
Ellis Salloum |
| Alejandro Solano Bayardo |
Nicole Bertram |
Mogilishetty PLLC
Phyo Kidney Care PA
RGV Kidney Care
Victory Kidney Clinic PA
William Restrepo MD PA
| Franklin Ponce Herrera |
| William Restrepo MD PA |
Mourad Alsabbagh, Practice
Independent Practitioners
| Mohammad Kotaki |
| Carlos Espinosa |
Preferred Providers
| Practice |
Provider Name |
| Transtreme LLC |
Rick Michel |
| Progressive Behavioral Health, PLLC |
|
| Psycare Inc |
|
| Rocky Mountain Kidney Care Professional Service Corp |
Yanique Cummings-Miller |
|
Michael Rendle |
|
Kara Bruning |
|
Tatianna Marx |
Joint Ventures
There are no joint ventures between or among the KCE and any of its KCE Participants and Preferred Providers.
Administrative Lead
| Name |
Employer |
| Phil Sarnowski |
U.S. Renal Care |
Clinical Lead
| Name |
Employer |
| Dr. Mike Rocklin |
U.S. Renal Care |
KCE Governing Body Members
| Name |
Employer |
| Reza Mizani |
South Texas Renal Care Group |
| Afzal Dudhia |
South Texas Renal Care Group |
| Laura Schammel |
South Texas Renal Care Group |
| Gautham Mogilishetty |
Mogilishetty PLLC |
| Michael Rocklin |
U.S. Renal Care |
| Phil Sarnowski |
U.S. Renal Care |
| Angie Simmons |
U.S. Renal Care |
| Rebecca Moore |
U.S. Renal Care |
| Lori Hartwell |
Consumer Advocate |
Shared Savings and Shared Losses Information
a. Gross Savings/Losses BEFORE CMS withholds:
PY2022: $2,230,155
PY2023 Shared Savings will be reported in 2026 when final reconciliations are released by CMS.
PY2024: $5,502,680
b. The amount of Shared Savings or Shared Losses, net of CMS Withholds and Aggregation:
PY2022: $521,114
PY2023 Shared Savings will be reported in 2026 when final reconciliations are released by CMS.
PY2024: $2,057,395
c. The proportion of Shared Savings invested in infrastructure, redesigned care processes, and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries; and
PY2022: 100%
PY2023 Shared Savings will be reported in 2026 when final reconciliations are released by CMS.
PY2024: 95%
d. The proportion of Shared Savings distributed to KCE Participants and Preferred Providers
PY2022: N/A
PY2023 Shared Savings will be reported in 2026 when final reconciliations are released by CMS.
PY2024: 5%
8. The KCE’s performance on the quality measures used to calculate the KCE’s TQS, as described in the Quality Overview Document and Measure Specifications Document.
Total Quality Score (TQS) results out of 100%, based on KCE quality measure performance during the period
Performance Year 2022 TQS: 75%
Performance Year 2023 TQS: 62.5%
Performance Year 2024 TQS: 60%
Earned High Performance Pool designation
9. Total Program Income to Participants (QCP, Transplant Bonus, Home Bonus, other income)
PY2022: $429,904
PY2023 Ancillary Income will be reported in 2026 when final reconciliations are released by CMS.
PY2024: $1,162,401
9. Total Program Income to Participants (QCP, Transplant Bonus, Home Bonus, other income)
PY2022: $429,904
PY2023 Ancillary Income will be reported in 2026 when final reconciliations are released by CMS.
PY2024: $1,162,401
